Chris Cain, Ph.D.

Chris Cain, Ph.D.

DirectoratCogent Biosciences· In proxies 2023–2025

Chris Cain, Ph.D. sits on 3 public boards.

Experience

  1. Cogent BiosciencesPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +199%
  2. Damora Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Jade Biosciences, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Viridian Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?